Clinical Trials · NCT02917057
Subanalyses of Elderly Type 2 Diabetes Patients or Type 2 Diabetes Patients With Renal Impairment
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- AstraZeneca
- Enrollment
- 6,024
- Start date
- Aug 2015
- Locations
- 1 site, United States
- Primary endpoint
- Changes from baseline in HbA1c (%)